BIOMEX performs 130th SARS-CoV-2 assay validation

We would like to take this time to thank our great customers and our highly dedicated IVD team.
Thanks to them, BIOMEX has successfully completed the 130th SARS-CoV-2 Ag assay validation!

In order to meet the high demand, BIOMEX has tripled its laboratory capacities and personnel infrastructure these last few months and established the entire validation process according to the current IVD regulation – from planning to sample collection and testing to the final report generation.

Working with us as your single and experienced full-service partner means the following for you:

Save valuable time for other jobs – while we control the entire process.
Realize the planned profits – because we provide high quality.
Reduce your time-to-market – since we deliver quickly and on time.

Are you also interested in conducting studies with other analytes? We are proven experts and are happy to support you in more complex and extensive projects with other analytes, e.g. HIV, hepatitis or syphilis.

Please contact for your individual offer.

This site is registered on as a development site.